IBCCES is the global leader in training and certification for healthcare professionals, educators and corporate partners who work with individuals with autism and other cognitive disorders. Our reach extends to more than 2 million people in all 50 states and over 70 countries around the globe. IBCCES Member Learning Community is provided as a free service to all IBCCES members who have completed one or more of our training and certification programs.
Science Saturday: Seeking a cellular therapy for chronic kidney disease
November 19, 2022
Every year, more than 130,000 people in the U.S. are diagnosed with end-stage kidney disease, with most cases caused by diabetes. Newer therapies show promise to slow kidney failure rates, but none stop progression to end-stage kidney failure. The research goal of LaTonya Hickson, M.D., is to develop a cell-based therapy that slows — or even stops — diabetic kidney disease from advancing to end-stage kidney disease. “It is going to take a multipronged approach. By utilizing…
Powered by WPeMatico